KWM
AMGN icon

Kingsview Wealth Management’s Amgen AMGN Stock Holding History

Kingsview Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200
Closed -$3K – 446
2019
Q2 		$3K Buy
200
+100
+100% +$17.9K ﹤0.01% 427
2019
Q1 		$1K Buy
+100
New +$19.1K ﹤0.01% 469
2017
Q3 		– Sell
-1,000
Closed -$1K – 366
2017
Q2 		$1K Buy
+1,000
New +$163K ﹤0.01% 324

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kingsview Wealth Management's AMGN Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Amgen (AMGN) stake by 48% in Q2 2026, selling an estimated $6.04M and leaving 18,729 shares worth $6.78M. The position accounts for 0.08% of the portfolio, ranked #225.

Kingsview Wealth Management first reported a position in AMGN in Q1 2017 and has held it in 38 quarters since. The position peaked at $18M in Q1 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kingsview Wealth Management held 18,729 shares of Amgen worth $6.78M as of Q2 2026.
  • Kingsview Wealth Management sold 17,636 Amgen shares in Q2 2026, an estimated $6.04M.
  • Amgen made up 0.08% of Kingsview Wealth Management's portfolio in Q2 2026, its #225 holding.
  • Kingsview Wealth Management first reported a position in Amgen in Q1 2017 and has held it in 38 quarters since.
  • Kingsview Wealth Management's Amgen position peaked at $18M in Q1 2024.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.